Clinical trial
Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate…
NCT00405392 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00405392 |
|---|---|
| Title | Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis |
| Official title | An Open-label, Multi-centre, Randomized Study to Investigate Patient Preference on Dosing in the Once-monthly Ibandronate and the Once-weekly Risedronate in Korean Women With Postmenopausal Osteoporosis. A Six-month, Two-sequence, and Two Period Crossover Study |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteoporosis, Postmenopausal |
| Intervention type | Drug |
| Interventions | Ibandronate (SB743830HD) |
| Enrollment | 365 |
| Start date | Mar 22, 2007 |
| Primary completion | May 27, 2008 |
| Completion | May 27, 2008 |
| First posted | Nov 30, 2006 |
| Last update posted | Jun 6, 2018 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: